[Acid anti-secretion therapy in gastric and duodenal ulcer].
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001570:Benzodiazepinones / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005663:Furans / Q000627:therapeutic use; D005750:Gastric Juice / Q000187:drug effects; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010890:Pirenzepine; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D011899:Ranitidine; D013276:Stomach Ulcer / Q000188:drug therapy*
D000863:Antacids; D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D005663:Furans; D005765:Gastrointestinal Agents; D006633:Histamine Antagonists; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D010890:Pirenzepine; D002927:Cimetidine; D011899:Ranitidine
Considerazioni sulla terapia antisecretiva-acida nell'ulcera gastrica e duodenale.